Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LANADELUMAB vs LAPATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LANADELUMAB vs LAPATINIB: Safety Overview

Metric LANADELUMAB LAPATINIB
Total FAERS Reports 2,058 1,983
Deaths Reported 109 267
Death Rate 5.3% 13.5%
Hospitalizations 1,007 498
Average Patient Age 47.3 yrs 54.1 yrs
% Female Patients 75.7% 96.6%
Manufacturer Takeda Pharmaceuticals America, Inc. N/A
Route SUBCUTANEOUS N/A